FERMT2, also known as Kindlin-2, has been associated with poor survival in lung adenocarcinoma [29] and hepatocellular carcinoma [30] and FERMT2 as well as other fermitin family members have been shown to promote EMT and metastasis through the ß catenin pathway [31–33]. Here, FERMT2 is linked to hepatocellular carcinoma.